BridgeMD
Compares treatment options for Papillary Thyroid Carcinoma
Official title Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
ClinicalTrials.gov ID: NCT06623578
What this study is testing
- What it's testing
- Thyroid cancer is one of the most common malignant tumors in women, ranking seventh in the United States and fourth in China. Papillary thyroid carcinoma is the most common pathological type (about 85% to 90% of thyroid cancers), and lateral cervical lymph node metastasis can reach 0.6-37.5% at diagnosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age 18-70 years old, male or female;
- papillary thyroid carcinoma with ipsilateral lateral cervical lymph node metastasis confirmed by FNAB;
- thyroid tumor of less than 3.0 cm in the largest diameter;
- lack of extrathyroidal extensions as estimated by preoperative ultrasonography and CT.
You likely can't join if
- level I or contralateral neck node metastases.
- enlarged lymph node of larger than 2.0 cm in the short diameter.
- suspected perinodal infiltration of metastatic lymph nodes.
- cervical or/and thoracic deformity.
- life-threatening diseases of liver, kidney, heart and other organs, or abnormal coagulation function.
- clinical evidence of distant metastases such as in the lung, bone, and so on.
See the full eligibility criteria
- Age 18-70 years old, male or female;
- papillary thyroid carcinoma with ipsilateral lateral cervical lymph node metastasis confirmed by FNAB;
- thyroid tumor of less than 3.0 cm in the largest diameter;
- lack of extrathyroidal extensions as estimated by preoperative ultrasonography and CT.
- level I or contralateral neck node metastases.
- enlarged lymph node of larger than 2.0 cm in the short diameter.
- suspected perinodal infiltration of metastatic lymph nodes.
- cervical or/and thoracic deformity.
- life-threatening diseases of liver, kidney, heart and other organs, or abnormal coagulation function.
- clinical evidence of distant metastases such as in the lung, bone, and so on.
- history of previous neck surgery and/or radiation therapy.
- intolerable to general anesthesia
- refuse either surgical procedure
- unwilling to cooperate with long-term follow-up evaluation.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.